Abnormal Schwann cell-axon interactions in CMT neuropathies: The effects of mutant Schwann cells on the axonal cytoskeleton and regeneration-associated myelination

Annals of the New York Academy of Sciences

Volumn 883, Issue , 1999, Pages 415-426

  Sahenk, Zarife ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MUS MUSCULUS;

CONNEXIN 32; GAP JUNCTION PROTEIN; MYELIN PROTEIN; PMP22 PROTEIN, HUMAN; PMP22 PROTEIN, MOUSE;

ANIMAL; ARTICLE; CYTOSKELETON; GENE DUPLICATION; GENETICS; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; MOUSE; NERVE FIBER; NERVE REGENERATION; NUDE MOUSE; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SCHWANN CELL; SCIATIC NERVE; SURAL NERVE; TRANSPLANTATION; ULTRASTRUCTURE; XENOGRAFT;

ANIMALS; AXONS; CHARCOT-MARIE-TOOTH DISEASE; CONNEXINS; CYTOSKELETON; GENE DUPLICATION; HUMANS; MICE; MICE, NUDE; MYELIN PROTEINS; NERVE REGENERATION; SCHWANN CELLS; SCIATIC NERVE; SURAL NERVE; TRANSPLANTATION, HETEROLOGOUS;

EID: 0033554346     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1999.tb08602.x     Document Type: Article

References (36)

1. AGUAYO, A.J., et al. 1977. Abnormal myelination in transplanted Trembler mouse Schwann cells. Nature 265: 73-75.
2. ALLEN, R.D., et al. 1982. Fast axonal transport in squid giant axon. Science 218: 1127-1129.
3. ANZINI, P., et al. 1997. Structural abnormalities and deficient maintenance of peripheral nerve myelin in mice lacking the gap junction protein connexin 32. J. Neurosci. 17: 4545-4551.
4. BAAS, P.W. & M.M. BLACK. 1990. Individual microtubules in the axon consist of domains that differ in both composition and stability. J. Cell Biol. 101: 495-509.
5. BERGOFFEN, J., et al. 1993. Connexin mutations in X-linked Charcot-Marie-Tooth disease. Science 262: 2039-2042.
6. BRIMIJOIN, S., P. CAPEK & P.J. DYCK. 1973. Axonal transport of dopamine-hydroxylase by human sural nerves in vitro. Science 180: 1295-1297.
7. DE WAEGH, S. & S.T. BRADY. 1990. Altered slow axonal transport and regeneration in a myelin-deficient mutant mouse: the trembler as an in vivo model for Schwann cell-axon interactions. J. Neurosci. 10: 1855-1865.
8. DE WAEGH, S.M. & S.T. BRADY. 1991. Local control of axonal properties by Schwann cells: neurofilaments and axonal transport in homologous and heterologous nerve grafts. J. Neurosci. Res. 30: 201-212.
9. DE WAEGH, S.M., V.M. LEE & S.T. BRADY. 1992. Local modulation of neurofilament phosphorylation, axonal caliber, and slow axonal transport by myelinating Schwann cells. Cell 68: 451-463.
10. DYCK, P.J. 1966. Histologic measurements, and fine structure of biopsied sural nerve: normal, and in peroneal muscular atrophy, hypertrophic neuropathy, and congenital sensory neuropathy. Mayo Clin. Proc. 41: 742-774.
11. DYCK, P.J., A.C. LAIS & K.P. OFFORD. 1974. The nature of myelinated nerve fiber degeneration in dominantly inherited hypertrophic neuropathy. Mayo Clin. Proc. 49: 34-39.
12. GRIFFIN, J.W., et al. 1985. Axonal transport of neurofilament proteins in IDPN neurotoxicity. Neurotoxicology 6: 43-53.
13. HOFFMAN, P.N., J.W. GRIFFIN & D.L. PRICE. 1984. Control of axonal caliber by neurofilament transport. J. Cell Biol. 99: 705-714.
14. HOFFMAN, P.N., et al. 1983. Slowing of the axonal transport of neurofilament proteins during development. J. Neurosci. 3: 1694-1700.
15. HOFFMAN, P.N., et al. 1985. Changes in neurofilament transport coincide temporally with alterations in the caliber of axons in regenerating motor fibers. J. Cell Biol. 101: 1332-1340.
16. KIRKPATRICK, L.L. & S.T. BRADY. 1994. Modulation of the axonal microtubule cytoskeleton by myelinating Schwann cells. J. Neurosci. 14: 7440-7450.
17. MAGYAR, J.P., et al. 1996. Impaired differentiation of Schwann cells in transgenic mice with increased PMP22 gene dosage. J. Neurosci. 16: 5351-5360.
18. PRINEAS, J. W. 1971. Ultrastructural changes in the peripheral nerves in experimental dying-back polyneuropathies. Proc. Aust. Assoc. Neurol. 8: 121-123.
19. ROA, B.B., et al. 1993. Dejerine-Sottas syndrome associated with point mutation in the peripheral myelin protein 22 (PMP22) gene. Nat. Genet. 5: 269-273.
20. SAHENK, Z. & J.R. MENDELL. 1981. Acrylamide and 2,5-hexanedione neuropathies: abnormal bidirectional transport rate in distal axons. Brain Res. 219: 397-405.
21. SAHENK, Z. & J.R. MENDELL. 1983. Studies on the morphologic alterations of axonal membranous organelles in neurofilamentous neuropathies. Brain Res. 268: 239-247.
22. SAHENK, Z. & S.T. BRADY. 1987. Axonal tuhulin and microtubules: morphologic evidence for stable regions on axonal microtubules. Cell Motil. Cytoskel. 8: 155-164.
23. SAHENK, Z., S.T. BRADY & J.R. MENDELL. 1987. Studies on the pathogenesis of vincristine-induced neuropathy. Muscle Nerve 10: 80-84.
24. SAHENK, Z. 1990. Distal terminal axonopathy produced by 2,4-dithiobiuret: effects of long-term intoxication in rats. Acta Neuropathol. 81: 141-147.
25. SAHENK, Z. & J.R. MENDELL. 1992. Alterations in slow transport kinetics induced by estramustine phosphate, an agent binding to microtubule-associated proteins. J. Neurosci. Res. 32: 481-493.
26. SAHENK, Z. & L. CHEN. 1998. Abnormalities in the axonal cytoskeleton induced by a connexin32 mutation in nerve xenografts. J. Neurosci. Res 51: 174-184.
27. SAHENK, Z., L. CHEN & M. FREIMER. 1998. A novel PMP22 point mutation causing HNPP phenotype: studies on nerve xenografts. Neurology 51: 702-707.
28. SAHENK, Z., L. CHEN & J.R. MENDELL. 1999. The effects of PMP22 duplication and deletions on the axonal cytoskeleton. Ann. Neurol. 45: 16-24.
29. SANCHEZ, I., et al. 1996. Oligodendroglia regulate the regional expansion of axon caliber and local accumulation of neurofilaments during development independently of myelin formation. J. Neurosci. 16: 5095-5105.
30. SEREDA, M., et al. 1996. A transgenic rat model of Charcot-Marie-Tooth disease. Neuron 16: 1049-1060.
31. SPENCER, P.S. & H.H. SCHAUMBURG. 1975. Nervous system dying-back disease produced by 2,5-hexanedione. Trans. Am. Neurol. Assoc. 100: 148-151.
32. SPENCER, P.S. & H.H. SCHAUMBURG. 1977. Ultrastructural studies of the dying-back process. IV. Differential vulnerability of PNS and CNS fibers in experimental central-peripheral distal axonopathies. J. Neuropathol. Exp. Neurol. 36: 300-320.
33. SPENCER, P.S. & H.H. SCHAUMBURG. 1977. Ultrastructural studies of the dying-back process. III. The evolution of experimental peripheral giant axonal degeneration. J. Neuropathol. Exp. Neurol. 36: 276-299.
34. WELCHER, A.A., et al. 1991. A myelin protein is encoded by the homologue of a growth arrest-specific gene. Proc. Natl. Acad. Sci. USA 88: 7195-7199.
35. YIN, X., et al. 1998. Myelin-associated glycoprotein is a myelin signal that modulates the caliber of myelinated axons. [Review] [49 refs]. J. Neurosci. 18: 1953-1962.
36. Trembler on cell growth of NIH3T3 fibroblasts. Cell Tissue Res. 287: 459-470.